Article thumbnail

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells

By M Comamala, M Pinard, C Thériault, I Matte, A Albert, M Boivin, J Beaudin, A Piché and C Rancourt
Topics: Molecular Diagnostics
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3065274
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
  2. (1994). b-Catenin mediates the interaction of the cadherin–catenin complex with epidermal growth factor receptor.
  3. (2006). Biol 135: 1899–1911
  4. (1987). Biologic therapy for the treatment of malignant common epithelial tumors of the ovary.
  5. (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28: 1153–1162 Thiery JP (2003) Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740–746 Tingulstad
  6. (2009). Chem 272: 12492–12494
  7. (2004). Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
  8. (2004). Miyajima A
  9. (2001). Obstet Gynecol 169: 725–730
  10. (2007). Physiol Cell Physiol 290: C1532–C1542
  11. (1993). Purification and characterization of the CA125 tumor-associated antigen from human ascites. Tumour Biol 14: 18–29 Gaetje
  12. (1996). Quantitative analysis of cadherin– catenin–actin reorganization during development of cell–cell adhesion.